Drug discovery: A modern decathlon

Angewandte Chemie - International Edition

Volumn 52, Issue 15, 2013, Pages 4072-4076

  Laufer, Stefan ^a   Holzgrabe, Ulrike ^b   Steinhilber, Dieter ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

drug development; medicinal chemistry; pharmaceutical industry

Indexed keywords

DRUG DEVELOPMENT; DRUG DISCOVERY; INCREASING COSTS; MEDICINAL CHEMISTRY; PHARMACEUTICAL INDUSTRY; PHARMACEUTICAL SCIENCE;

CATALYSIS; CHEMISTRY;

DRUG PRODUCTS;

DRUG;

DRUG DEVELOPMENT; DRUG INDUSTRY; ECONOMICS; HUMAN; REVIEW;

DRUG DISCOVERY; DRUG INDUSTRY; HUMANS; PHARMACEUTICAL PREPARATIONS;

EID: 84875843165     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201210006     Document Type: Review

References (31)

1. R. Mullin, Chem. Eng. News 2012, 90 (50), 15- 20
2. B. Hirschler, C. Humer, Reuthers Report http://www.reuters.com/article/ 2012/12/31/us-pharmaceuticals-fda-approvals-idUSBRE8BU0EK20121231.
3. M. Wadman, Nature 2012, 481, 128
4. T. Gura, Nature 2012, 492, 143-144.
5. W. L. Jorgensen, Angew. Chem. 2012, 124, 11848-11853
6. Angew. Chem. Int. Ed. 2012, 51, 11680-11684
7. H. Waldmann, Angew. Chem. 2012, 124, 6388-6389
8. Angew. Chem. Int. Ed. 2012, 51, 6284-6285
9. B. Meunier, Angew. Chem. 2012, 124, 8832-8837
10. Angew. Chem. Int. Ed. 2012, 51, 8702-8706
11. H. Wild, C. Huwe, M. Lessl, Angew. Chem. 2013, 125, 2748-2751
12. Angew. Chem. Int. Ed. 2013, 52, 2684-2687.
13. J. A. DiMasi, R. W. Hansen, H. G. Grabowski, J. Health Econ. 2003, 22, 151-185.
14. G. M. Milne, Jr., Ann. Rep. Med. Chem. 2003, 38, 383-396.
15. R. Kneller, Nat. Rev. Drug Discovery 2010, 9, 867-882.
16. R. L. Elliott, ACS Med. Chem. Lett. 2012, 3, 688-690.
17. D. B. Lowe, ACS Med. Chem. Lett. 2012, 3, 3-4.
18. S. L. Schreiber, Proc. Natl. Acad. Sci. USA 2011, 108, 6699-6702.
19. B. Over, S. Wetzel, C. Grütter, Y. Nakai, S. Renner, D. Rauh, H. Waldmann, Nat. Chem. 2013, 5, 21-28.
20. P. Kolb, G. Klebe, Angew. Chem. 2011, 123, 11778-11780
21. Angew. Chem. Int. Ed. 2011, 50, 11573-11575
22. S. Granier, B. Kobilka, Nat. Chem. Biol. 2012, 8, 670-673.
23. F. Zaragoza, Lead Optimization for Medicinal Chemists: Pharmacokinetic Properties of Functional Groups and Organic Compounds, Wiley-VCH, Weinheim, 2012, Chap. 1.
24. J.-U. Peters, Polypharmacology in Drug Discovery, Wiley, Hoboken, 2012.
25. F. Broccatelli, G. Cruciani, L. Z. Benet, T. I. Oprea, Mol. Pharmaceutics 2012, 9, 570-580
26. Y. Yang, O. Engkvist, A. Llinàs, H. Chen, J. Med. Chem. 2012, 55, 3667-3677.
27. C. A. Lipinski, F. Lombardo, B. W. Dominy, P. J. Feeney, Adv. Drug Delivery Rev. 1997, 23, 3-25.
28. M. M. Hann, Med. Chem. Commun. 2011, 2, 349-355.
29. M. M. Hann, G. M. Keserü, Nat. Rev. Drug Discovery 2012, 11, 355-365.
30. R. A. Galemmo, Jr., F. E. Janssens, P. J. Lewi, B. E. Maryanoff, J. Med. Chem. 2005, 48, 1686.
31. D. P. Rotella, ACS Med. Chem. Lett. 2012, 3, 172-173.